0
Feedback Feedback

<< Evidence-Based Management Of Kawasaki Disease In The Emergency Department

Disposition

Patients with suspected Kawasaki disease, either complete or incomplete, should be admitted to an appropriate pediatric inpatient facility. Treatment for Kawasaki disease involves, at a minimum, an infusion of IVIG, which is typically given over a period of hours. Side effects of this medication may include fever, headache, urticaria, nausea, vomiting, and blood pressure instability. Although uncommon, anaphylaxis, Stevens-Johnson syndrome, and nephrotoxicity have been reported, so it is in the best interest of the patient to be admitted for monitoring during treatment.

To continue reading, please log in or purchase access.

 

Already purchased this course?
Log in to read.
Purchase a subscription

Price: $449/year

140+ Credits!

Money-back Guarantee
Get Quick-Read Evidence-Based Updates
Enter your email to get free evidence-based content delivered to your inbox once per month.
Please provide a valid email address.